Article Information
PubMed
Published By
History
- Received April 24, 2020
- Accepted June 2, 2020
- Published online August 25, 2020.
Article Versions
- Previous version (July 14, 2020 - 16:30).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2020, The Authors This article is Open Access: CC BY license (https://creativecommons.org/licenses/by/4.0/)
Author Information
- Hajira Dambha-Miller1,
- Ali Albasri2,
- Sam Hodgson3,*,
- Christopher Wilcox3,
- Nazrul Islam4,5,
- Shareen Khan6,
- Paul Little7 and
- Simon Griffin8
- 1 NIHR Academic Clinical Lecturer and GP, Division of Primary Care and Population Health, University of Southampton, Southampton, UK
- 2 Clinical Pharmacist and Research Fellow, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
- 3 NIHR Academic Clinical Fellow, Division of Primary Care and Population Health, University of Southampton, Southampton, UK
- 4 Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
- 5 Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, UK
- 6 Specialist Pharmacist, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
- 7 Professor of Primary Care, Division of Primary Care and Population Health, University of Southampton, Southampton, UK
- 8 Professor of General Practice, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, UK
- ↵
*For correspondence:
Sam Hodgson, samcbhodgson{at}gmail.com
Article usage
Statistics from Altmetric.com
In this issue
Drug treatments affecting ACE2 in COVID-19 infection: a systematic review protocol
Jump to section
More in this TOC Section
Related Articles
Cited By...
Intended for Healthcare Professionals
